- Patent Title: Method and biomarkers for the detection of dengue hemorrhagic fever
-
Application No.: US14124343Application Date: 2012-06-06
-
Publication No.: US10168337B2Publication Date: 2019-01-01
- Inventor: Allan Brasier , Adrian Recinos , John E. Wiktorowicz , Heidi Spratt , Hyunsu Ju , Nikos Vasilakis , Ernesto E. T. Marquez , Marli Tenorio , Laura H. V. G. Gil , Eduardo Nascimento
- Applicant: Allan Brasier , Adrian Recinos , John E. Wiktorowicz , Heidi Spratt , Hyunsu Ju , Nikos Vasilakis , Ernesto E. T. Marquez , Marli Tenorio , Laura H. V. G. Gil , Eduardo Nascimento
- Applicant Address: US TX Austin
- Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Norton Rose Fulbright US LLP
- International Application: PCT/US2012/041131 WO 20120606
- International Announcement: WO2012/170556 WO 20121213
- Main IPC: G01N33/68
- IPC: G01N33/68 ; G01N33/564 ; G01N33/569
Abstract:
The present invention provides compositions and methods for detecting, analyzing, and identifying biomolecules used to diagnose patient with risk of DHF. More particularly, the invention provides plasma biomarkers including complement factor D to complement factor H (FactorD/FactorH) ratio and levels of one or more of IL2, desmoplakin, and high molecular weight albumin, which are used to detect risk of developing DHF.
Public/Granted literature
- US20160003845A1 Method and Biomarkers for the Detection of Dengue Hemorrhagic Fever Public/Granted day:2016-01-07
Information query
IPC分类:
